SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,528,584 | +6.5% | 12,610 | +0.6% | 0.02% | +10.5% |
Q2 2023 | $1,435,852 | -9.3% | 12,538 | +9.1% | 0.02% | -17.4% |
Q1 2023 | $1,583,253 | +7.2% | 11,487 | +0.8% | 0.02% | -4.2% |
Q4 2022 | $1,476,435 | +34.7% | 11,394 | +14.9% | 0.02% | +14.3% |
Q3 2022 | $1,096,000 | +48.3% | 9,917 | +0.5% | 0.02% | +40.0% |
Q2 2022 | $739,000 | +0.8% | 9,863 | +5.1% | 0.02% | +25.0% |
Q1 2022 | $733,000 | -12.7% | 9,384 | +0.6% | 0.01% | -7.7% |
Q4 2021 | $840,000 | +6.1% | 9,332 | +9.0% | 0.01% | -13.3% |
Q3 2021 | $792,000 | +14.5% | 8,560 | -3.9% | 0.02% | +15.4% |
Q2 2021 | $692,000 | +18.9% | 8,905 | +14.0% | 0.01% | +8.3% |
Q1 2021 | $582,000 | -56.3% | 7,810 | -0.1% | 0.01% | -58.6% |
Q4 2020 | $1,333,000 | +22.7% | 7,821 | +1.1% | 0.03% | +7.4% |
Q3 2020 | $1,086,000 | -12.8% | 7,733 | -0.5% | 0.03% | -15.6% |
Q2 2020 | $1,246,000 | – | 7,772 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |